CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia

Neuro-Oncology

Volumn 15, Issue 7, 2013, Pages 865-879

  Mao, Xing Gang ^a,d   Xue, Xiao Yan ^b   Wang, Liang ^b   Zhang, Xiang ^a   Yan, Ming ^a   Tu, Yan Yang ^b   Lin, Wei ^a   Jiang, Xiao Fan ^a   Ren, Hong Gang ^c   Zhang, Wei ^a   Song, Shao Jun ^d  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Linfen People's Hospital   (China)

^d Chinese PLA 254 Hospital   (China)

Author keywords

bioinformatics; brain tumor stem cells; cancer stem cell; hypoxia; VE cadherin

Indexed keywords

CDH5; CELL MARKER; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER GRADING; CANCER PROGNOSIS; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE SILENCING; GLIOBLASTOMA; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEURAL STEM CELL; NONHUMAN; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UPREGULATION;

BIOINFORMATICS; BRAIN TUMOR STEM CELLS; CANCER STEM CELL; HYPOXIA; VE-CADHERIN;

ADULT; ANIMALS; ANOXIA; ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CADHERINS; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEURAL STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84879407973     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not029     Document Type: Article

References (61)

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet. 2003; 361(9354): 323-331. (Pubitemid 36126198)
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10): 987-996. (Pubitemid 40349501)
3. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004; 432(7015): 396-401. (Pubitemid 39551674)
4. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006; 6(6): 425-436.
5. Mao XG, Zhang X, Zhen HN. Progress on potential strategies to target brain tumor stem cells. Cell Mol Neurobiol. 2009; 29(2): 141-155.
6. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859): 105-111. (Pubitemid 33041634)
7. Charles N, Ozawa T, Squatrito M, et al. Perivascular nitric oxide activates Notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 2010; 6(2): 141-152.
8. Seidel S, Garvalov BK, Wirta V, et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain. 2010; 133(Pt 4): 983-995.
9. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007; 11(1): 69-82. (Pubitemid 46054518)
10. Li Z, Bao S, Wu Q, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6): 501-513.
11. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol. 2010; 177(3): 1491-1502.
12. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120): 756-760. (Pubitemid 44949604)
13. Lu C, Shervington A. Chemoresistance in gliomas. Mol Cell Biochem. 2008; 312(1-2): 71-80.
14. Eramo A, Ricci-Vitiani L, Zeuner A, et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 2006; 13(7): 1238-1241. (Pubitemid 43905604)
15. Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 2010; 468(7325): 829-833.
16. Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010; 468(7325): 824-828.
17. Soda Y, Marumoto T, Friedmann-Morvinski D, et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A. 2011; 108(11): 4274-4280.
18. El Hallani S, Boisselier B, Peglion F, et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain. 2010; 133(Pt 4): 973-982.
19. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009; 15(3): 220-231.
20. Keunen O, Johansson M, Oudin A, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A. 2011; 108(9): 3749-3754.
21. Carmeliet P, Lampugnani MG, Moons L, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 1999; 98(2): 147-157. (Pubitemid 29344903)
22. Bach TL, Barsigian C, Chalupowicz DG, et al. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res. 1998; 238(2): 324-334. (Pubitemid 28372819)
23. Corada M, Zanetta L, Orsenigo F, et al. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood. 2002; 100(3): 905-911. (Pubitemid 34832616)
24. Liao F, Li Y, O'Connor W, et al. Monoclonal antibody to vascular endothelial- cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res. 2000; 60(24): 6805-6810. (Pubitemid 32059142)
25. Mao XG, Zhang X, Xue XY, et al. Brain tumor stem-like cells identified by neural stem cell marker CD15. Transl Oncol. 2009; 2(4): 247-257.
26. Mao XG, Yan M, Xue XY, et al. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors. Lab Invest. 2011; 91(7): 1068-1078.
27. Margolin AA, Nemenman I, Basso K, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics. 2006; 7(Suppl 1): S7.
28. TCGA. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455(7216): 1061-1068.
29. VerhaakRG, Hoadley KA, PurdomE, et al. Integratedgenomic analysis identifies clinically relevant subtypes of glioblastomacharacterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1): 98-110.
30. Gravendeel LA, Kouwenhoven MC, Gevaert O, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 2009; 69(23): 9065-9072.
31. Lee Y, Scheck AC, Cloughesy TF, et al. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics. 2008; 1: 52.
32. Carro MS, Lim WK, Alvarez MJ, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010; 463(7279): 318-325.
33. Sharma S, Sharma MC, Gupta DK, Sarkar C. Angiogenic patterns and their quantitation in high grade astrocytic tumors. J Neurooncol. 2006; 79(1): 19-30. (Pubitemid 44057411)
34. Folkerth RD. Descriptive analysis and quantification of angiogenesis in human brain tumors. J Neurooncol. 2000; 50(1-2): 165-172. (Pubitemid 32166298)
35. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5): 391-403. (Pubitemid 43668737)
36. Mao XG, Guo G, Wang P, et al. Maintenance of critical properties of brain tumor stem like cells after cryopreservation. Cell Mol Neurobiol. 2010; 30(5): 775-786.
37. Margolin AA, Wang K, Lim WK, Kustagi M, Nemenman I, Califano A. Reverse engineering cellular networks. Nat Protoc. 2006; 1(2): 662-671.
38. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A. Reverse engineering of regulatory networks in human B cells. Nat Genet. 2005; 37(4): 382-390.
39. Liu Y, Carson-Walter EB, Cooper A, Winans BN, Johnson MD, Walter KA. Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol. 2010; 99(1): 13-24.
40. Wallgard E, Larsson E, He L, et al. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler Thromb Vasc Biol. 2008; 28(8): 1469-1476.
41. Yuan L, Sacharidou A, Stratman AN, et al. RhoJ is an endothelial cellrestricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Blood. 2011; 118(4): 1145-1153.
42. Birdsey GM, Dryden NH, Amsellem V, et al. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood. 2008; 111(7): 3498-3506.
43. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 1997; 11(1): 72-82. (Pubitemid 27043825)
44. Le Bras A, Lionneton F, Mattot V, et al. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene. 2007; 26(53): 7480-7489. (Pubitemid 350158718)
45. Soeda A, Park M, Lee D, et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene. 2009; 28(45): 3949-3959.
46. Mendez O, Zavadil J, Esencay M, et al. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer. 2010; 9: 133.
47. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 2009; 8(20): 3274-3284.
48. Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996; 271(51): 32529-32537.
49. Mole DR, Blancher C, Copley RR, et al. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem. 2009; 284(25): 16767-16775.
50. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003; 9(6): 677-684. (Pubitemid 36749216)
51. Mazumdar J, O'Brien WT, Johnson RS, et al. O(2) regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol. 2010; 12(10): 1007-1013.
52. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129(3): 465-472. (Pubitemid 46660978)
53. Platet N, Liu SY, Atifi ME, et al. Influence of oxygen tension onCD133 phenotype in human gliomacell cultures. Cancer Lett. 2007; 258(2): 286-290. (Pubitemid 350110377)
54. Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008; 8(12): 967-975.
55. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression.Nature. 2006; 441(7092): 437-443.
56. Semenza GL. Life with oxygen. Science. 2007; 318(5847): 62-64. (Pubitemid 47538005)
57. Kaelin WG, Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008; 30(4): 393-402. (Pubitemid 351681994)
58. Labelle M, Schnittler HJ, Aust DE, et al. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. Cancer Res. 2008; 68(5): 1388-1397. (Pubitemid 351346846)
59. Wurmser AE, Nakashima K, Summers RG, et al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature. 2004; 430(6997): 350-356. (Pubitemid 38937742)
60. Xia X, Kung AL. Preferential binding of HIF-1 to transcriptionally active loci determines cell-type specific response to hypoxia. Genome Biol. 2009; 10(10): R113.
61. Lou F, Chen X, Jalink M, et al. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase. Mol Cancer Res. 2007; 5(8): 793-800. (Pubitemid 47294807)